l carnitine fatty acid metabolism L-Carnitine in Mitochondria Frontiers | L–carnitine in metabolic

Use within 6 months

In addition, obesity could inhibit hepatic utilization of BCAAs and cause the inactivation of BCKDH by increasing the ratio of BCKDK (BCKDH kinase)/PPM1K (BCKDH dephosphorylase) in hepatocytes

Certain health conditions, such as pernicious anemia or specific gastrointestinal disorders that affect B12 absorption, may require even longer-term or lifelong monthly injections

Under stress or diseased conditions (e.g., heat stress, infection, obesity, diabetes, and cancer), taurine synthesis in the body may be impaired due to the suboptimal function of liver and the reduced availability of the amino acid precursors

The hemolysis ratio was calculated by the following formula: Hemolysis ratio (%) = (OD sample OD negative ) / (OD positive OD negative ) 100